@drtimos.bsky.social

5 days ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TRw3xP | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

2 weeks ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TRlzSv | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

3 weeks ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TRbhNz | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

1 month ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TRQ0Nr | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

1 month ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TRDW4Q | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

1 month ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TR3wvy | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

2 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TQvDfR | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

2 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TQjh25 | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

2 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TQYBXy | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

2 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TQPMnk | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

3 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TQFHXB | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

3 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TQ66mM | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

3 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TQ0vhK | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

3 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TPtYqp | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

4 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TPlsX3 | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

4 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TPcRBK | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

4 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TPTXKJ | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

4 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TPLbcL | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

5 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TPCTDk | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

5 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TP462H | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

5 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TNx1TN | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

5 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TNpDMT | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

5 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TNg1YC | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

6 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TNWk61 | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest

@drtimos.bsky.social

6 months ago

BioPharma (+ Google) Corporate Venture Capital Investment Trends: Who is leading in 2025? Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? info@lqventures.com LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TNMSdy | 📧 Talk to experts: info@lqventures.com
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest